Moksisilit

Moksisilit
(IUPAC) ime
	4-[2-(Dimetilamino)etoksi]-5-izopropil-2-metilfenil acetat
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	54-32-0
ATC kod	G04BE06 C04AX10
PubChem	4260
UNII	PW8QYA7KI0
KEGG	D08239
Hemijski podaci
Formula	C16H25NO3
Mol. masa	279,375 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3 ; Key: VRYMTAVOXVTQEF-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Moksisilit (timoksamin) je lek koji se koristi u urologiji za tretman erektilne disfunkcije. On je antagonist α₁-adrenergičkog receptora.^[4]

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). „Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte”. J. Auton. Nerv. Syst. 79 (2–3): 191–5. DOI:10.1016/S0165-1838(99)00105-8. PMID 10699651.

	Portal Medicina
	Portal Hemija

Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).